Trexquant Investment LP Cytom X Therapeutics, Inc. Transaction History

Trexquant Investment LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$6.33 - $9.91 $87,417 - $136,857	-13,810 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$6.6 - $9.0 $42,259 - $57,627	-6,403 Reduced 31.68%	13,810 $107,000
Q4 2020 Feb 11, 2021	SELL	$6.47 - $7.9 $372,348 - $454,645	-57,550 Reduced 74.01%	20,213 $132,000
Q3 2020 Nov 06, 2020	SELL	$6.55 - $8.83 $330,847 - $446,012	-50,511 Reduced 39.38%	77,763 $517,000
Q2 2020 Aug 07, 2020	BUY	$7.4 - $14.64 $812,986 - $1.61 Million	109,863 Added 596.72%	128,274 $1.07 Million
Q1 2020 May 08, 2020	BUY	$3.61 - $8.6 $66,463 - $158,334	18,411 New	18,411 $141,000
Q4 2019 Feb 12, 2020	SELL	$5.17 - $8.91 $66,460 - $114,538	-12,855 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$7.38 - $12.25 $8,951 - $14,859	1,213 Added 10.42%	12,855 $95,000
Q2 2019 Aug 09, 2019	SELL	$9.35 - $11.41 $195,302 - $238,332	-20,888 Reduced 64.21%	11,642 $131,000
Q1 2019 May 13, 2019	BUY	$9.5 - $19.16 $309,035 - $623,274	32,530 New	32,530 $350,000
Q3 2018 Nov 09, 2018	SELL	$18.04 - $26.41 $354,846 - $519,484	-19,670 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$21.38 - $29.68 $99,374 - $137,952	-4,648 Reduced 19.11%	19,670 $450,000
Q1 2018 May 03, 2018	BUY	$21.76 - $34.22 $529,159 - $832,161	24,318 New	24,318 $692,000
Q4 2017 Feb 09, 2018	SELL	$19.0 - $23.09 $496,090 - $602,879	-26,110 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$13.53 - $18.17 $353,268 - $474,418	26,110	26,110 $474,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.